119 related articles for article (PubMed ID: 38301135)
1. Interleukin-36gamma Mediates the
Zhou Y; Chen J; Bai S; Yang F; Yan R; Song Y; Yang B; Li C; Wang J
Viral Immunol; 2024; 37(1):24-35. PubMed ID: 38301135
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia.
Xin T; Xing R; Jiang H; Jin F; Li M
Int Immunopharmacol; 2024 Mar; 129():111513. PubMed ID: 38301411
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.
Pallikkuth S; Rogers K; Villinger F; Dosterii M; Vaccari M; Franchini G; Pahwa R; Pahwa S
Vaccine; 2011 Nov; 29(49):9229-38. PubMed ID: 21996099
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques.
Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C
Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD8
Perdomo-Celis F; Arcia-Anaya D; Alzate JC; Velilla PA; Díaz FJ; Posada MP; Rugeles MT; Taborda NA
AIDS Res Ther; 2022 Sep; 19(1):42. PubMed ID: 36104716
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.
Parmigiani A; Pallin MF; Schmidtmayerova H; Lichtenheld MG; Pahwa S
Hum Immunol; 2011 Feb; 72(2):115-23. PubMed ID: 20977918
[TBL] [Abstract][Full Text] [Related]
7. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
Sun M; Xing H
Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
[TBL] [Abstract][Full Text] [Related]
9. [Increased Notch receptors induces CD8(+) T cell exhaustion in patients with prostate cancer].
Wang RX; Li YF; Hao CH; Fang W
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2669-2674. PubMed ID: 32921015
[No Abstract] [Full Text] [Related]
10. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
11. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
[TBL] [Abstract][Full Text] [Related]
12. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure].
Yu HW; Dong YY; Dang YH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439
[No Abstract] [Full Text] [Related]
13. Interleukin-35 Suppresses CD8
Yang L; Zhang Q; Song J; Wang W; Jin Z
Dig Dis Sci; 2020 Dec; 65(12):3614-3623. PubMed ID: 31974915
[TBL] [Abstract][Full Text] [Related]
14. Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.
Nakiboneka R; Mugaba S; Auma BO; Kintu C; Lindan C; Nanteza MB; Kaleebu P; Serwanga J
Vaccine; 2019 Jan; 37(1):113-122. PubMed ID: 30459072
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV).
White L; Krishnan S; Strbo N; Liu H; Kolber MA; Lichtenheld MG; Pahwa RN; Pahwa S
Blood; 2007 May; 109(9):3873-80. PubMed ID: 17192392
[TBL] [Abstract][Full Text] [Related]
16. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
[TBL] [Abstract][Full Text] [Related]
17. IL-36β Promotes CD8
Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
Front Immunol; 2019; 10():1803. PubMed ID: 31447838
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
19. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents.
Haridas V; McCloskey TW; Pahwa R; Pahwa S
AIDS; 2003 Nov; 17(16):2313-22. PubMed ID: 14571182
[TBL] [Abstract][Full Text] [Related]
20. Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA.
Zou W; Foussat A; Capitant C; Durand-Gasselin I; Bouchet L; Galanaud P; Levy Y; Emilie D
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):31-8. PubMed ID: 10534144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
